baber/WOPTO huggingface dataset:
Patent AU-2021204066-A1 (AU)
Title: Bracket assembly for a jack
Inventor: GILL ASHLEY
IPC: B60D1/66
Filed: 2021-06-18
Abstract: (Figure 1) 
A jack 12 and bracket assembly 27 shown fitted to a rail 11. The jack is an electric jack 12 
having a drive section 13 with controls 14. The jack has an outer tube 15 and a retractable inner 
tube 16 telescopically fitted within the outer tube 15. The outer tube has part way along it, an 
annular mounting flange 17 with mounting holes 18, 19, 20, 21 and 22. Multiple bolts 23, nuts 
24 and washers 25 pass through the holes to secure the annular flange 23 to an upper plate 26 
of bracket assembly 27. The bracket assembly 27 has a lower plate 28 vertically spaced from 
the upper plate 26. The outer tube 15 passes through both of these plates. It is secured by the 
mounting flange to the top plate so there is no need for any securement to the bottom plate 28.  
The top plates and bottom plates 27 and 28 project out from a first clamp plate 29. This is held 
in position by being clamped using second clamp plate 30 by reason of fasteners 31, four of 
which are employed between the respective clamp plates.
1/5 
13 
12 
14 
23 32 
15 
X 17 
22,1 
30 19 
27,
31 
20 21 
26--- 
2 5 
29
-10 
33 
31 
28 
16 
V11 FIG.1
Patent AU-2021245219-A1 (AU)
Title: Nasal implants and systems and method of use
Inventor: BARON SCOTT J
IPC: A61B17/24
Filed: 2021-10-08
Abstract: There is disclosed a method of forming a nasal implant comprising: 
forming an implant core comprising 
a distal end, 
a proximal end, 
a central portion disposed between the proximal end and the distal end, 
a first arm disposed at the distal end, the arm having a proximal end fixed to 
the central portion and a distal end not fixed to the central portion, the 
distal end of the first arm being adapted to move away from a central 
longitudinal axis of the central portion from a delivery configuration 
toward a deployed configuration, and 
a second arm having a proximal end fixed to the central portion and a distal 
end not fixed to the central portion, the distal end of the second arm 
being adapted to move away from a central longitudinal axis of the 
central portion from a delivery configuration toward a deployed 
configuration, 
wherein the first arm is biased toward the deployed configuration and the 
second arm is biased toward the deployed configuration, and 
wherein the implant core comprises a degradable material; and 
applying a degradable coating on an outer surface of the implant core, 
wherein the degradable coating and the implant core do not deliver a pharmaceutical 
agent or a drug.
Patent AU-2021246099-A1 (AU)
Title: Compositions and methods for modulating inflammatory response
Inventor: STAMETS PAUL E
IPC: A61K36/07
Filed: 2021-04-02
Abstract: Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mushroom mycelium and/or fruit body mixture, optionally combined with one or more buffering agents, ethanol, and water.
Patent AU-2021253751-A1 (AU)
Title: Medical devices for repairing perforations in tissue, methods of manufacturing medical devices, and methods of implanting a medical device
Inventor: DE POIX ALEX
IPC: A61F2/18
Filed: 2021-04-09
Abstract: Medical devices for repairing perforations in tissue, such as the tissue forming the tympanic membrane, methods of manufacturing medical devices, and methods of implanting a medical device are described. An example method of manufacturing a medical device (800) includes obtaining a first piece of material (810), obtaining a second piece of material (840), obtaining a divider (870) defining an passageway (876) that extends through the divider (870), positioning the divider (870) between the first piece of material (810) and the second piece of material (840) such that the divider (870) contacts the first piece of material (810) and the second piece of material (840), attaching a portion of the first piece of material (810) to a portion of the second piece of material (840) within the passageway (876) defined by the divider (870), and removing the divider (870) from between the first piece of material (810) and the second piece of material (840).
Patent AU-2021261147-A1 (AU)
Title: Modified macrophages, compositions and uses thereof
Inventor: SU HONG-LIN
IPC: C12N5/0786
Filed: 2021-04-19
Abstract: The present invention provides modified monocytes, modified macrophages, pharmaceutical compositions comprising the modified monocytes or modified macrophages described herein and at least one pharmaceutically acceptable carrier or excipient. Uses of the modified monocytes or the modified macrophages for the treatment of musculoskeletal diseases and inducing cartilage formation are provided. Also disclosed herein are in vitro culture methods for generating the modified macrophages.
Patent AU-2021261230-A1 (AU)
Title: Guanidine-modified C-terminus vancomycin compounds, compositions and methods
Inventor: BOGER DALE L
IPC: A61P31/04
Filed: 2021-04-13
Abstract: A series of vancomycin C-terminus guanidine modifications are disclosed that improve antimicrobial activity, enhance the durability of antimicrobial action against selection or induction of resistance, and provide two synergistic mechanisms of action independent of D-Ala-D-Ala binding that cause inhibition of cell wall biosynthesis, while inducing bacterial cell permeability. A contemplated compound contains two combined peripheral modifications, a (4-chlorobiphenyl)methyl (CBP) and C-terminus guanidine modification, that provide new treatments against not only vancomycin-sensitive, but especially vancomycin- resistant bacteria. The data demonstrate that the synergistic behavior of the peripheral modifications requires the presence of both the CBP and guanidine modifications in a single molecule versus their combined use as an equimolar mixture of singly modified compounds. A prototypical member of the series, G3- CBP-vancomycin (15), exhibits no hemolytic activity, displays no mammalian cell growth inhibition, and possesses improved and especially attractive in vivo pharmacokinetic (PK) properties.
Patent AU-2021262336-A1 (AU)
Title: Double-layer osteochondral tissue repair stent and preparation method therefor
Inventor: FAN DAIDI
IPC: A61L27/48
Filed: 2021-04-29
Abstract: Provided in the present invention is a preparation method for a double-layer osteochondral tissue repair stent, comprising: formulating a first feed solution, the first feed solution comprising recombinant collagen, sodium hyaluronate, and hydroxyapatite; formulating a second feed solution, the second feed solution comprising recombinant collagen and sodium hyaluronate; freeze-drying the first feed solution and the second feed solution and forming a gel-like double-layer structure; and adding the gel-like double-layer structure into a crosslinking agent for crosslinking. The present method also relates to a double-layer osteochondral tissue repair stent, comprising: a first layer composed of raw materials including recombinant collagen, sodium hyaluronate, and hydroxyapatite; and a second layer composed of raw materials including recombinant collagen and sodium hyaluronate. The double-layer osteochondral tissue repair stent prepared by the present invention has excellent mechanical properties, good biocompatibility, and a suitable degradation rate and, after degradation, the stent material can be reused as raw material for the formation of new bone, thus implementing osteochondral tissue repair.
Patent AU-2021275032-A1 (AU)
Title: Optimizing communication in distributed computing network
Inventor: STANFILL CRAIG W
IPC: H04L47/263
Filed: 2021-05-18
Abstract: A computing system includes a distributed computing cluster including a plurality of computing nodes interconnected by an interconnect network over which the computing nodes of the plurality of computing nodes communicate with each other by passing messages. The computing nodes are configured with a first parameter governing transmissions of messages by the computing nodes over the interconnect network. The computing nodes are configured to accumulate messages for transmission as a group of messages according to the first parameter, and the computing system is configured to limit injections of computing requests into the distributed computing cluster according to a second parameter. A controller is configured to receive at least one predetermined service level requirement and to control a value of the second parameter and a value of the first parameter to control a computational throughput of the distributed computing cluster while complying with the at least one service level requirement.
Patent AU-2021277693-A1 (AU)
Title: Data driven speech enabled self-help systems and methods of operating thereof
Inventor: LEV YONI
IPC: G10L15/22
Filed: 2021-12-01
Abstract: DATA DRIVEN SPEECH ENABLED SELF-HELP SYSTEMS AND METHODS OF 
OPERATING THEREOF 
ABSTRACT 
5 A method for configuring an automated, speech driven self-help system based on 
prior interactions between a plurality of customers and a plurality of agents includes: 
recognizing, by a processor, speech in the prior interactions between customers 
and agents to generate recognized text; detecting, by the processor, a plurality of 
phrases in the recognized text; clustering, by the processor, the plurality of phrases 
10 into a plurality of clusters; generating, by the processor, a plurality of grammars 
describing corresponding ones of the clusters; outputting, by the processor, the 
plurality of grammars; and invoking configuration of the automated self-help system 
based on the plurality of grammars.
Patent AU-2021279010-A1 (AU)
Title: Biodegradable high-performance absorbent polymers and methods thereof
Inventor: FLYNN ALLISON
IPC: C12P13/02
Filed: 2021-05-26
Abstract: Among other things, the present disclosure provides technologies useful as super absorbent polymers.
Patent AU-2021283041-A1 (AU)
Title: Transaction cards with discontinuous metal strata
Inventor: LOWE ADAM
IPC: G06K19/02
Filed: 2021-05-27
Abstract: A transaction card having a discontinuous metal stratum (14) with a desired degree of electrical eddy current disruption disposed on a surface of a first layer (12), such as a glass or other transparent layer. A transaction module (16) disposed in the first layer is electrically isolated from the discontinuous metal stratum. The discontinuous metal stratum may include a plurality of isolated metal features (15) that form a halftone pattern, such as a pattern that is visibly opaque to the naked eye.
Patent AU-2021301190-A1 (AU)
Title: Compositions and methods for reprogramming skin tissue to have insulinogenic and delivery functions
Inventor: SEN CHANDAN K
IPC: C12N15/85
Filed: 2021-06-25
Abstract: Disclosed herein are compositions and
Patent AU-2021331681-A1 (AU)
Title: Composition and method
Inventor: TROTTA FEDERICO
IPC: B22F1/00
Filed: 2021-08-23
Abstract: Compositions comprising extracts of kale and a number of other plants in synergistic mixtures are disclosed. A method of forming a metal nanoparticle and a nanoparticle formed using the method are disclosed.
Patent AU-2021340972-A1 (AU)
Title: Vectorized antibodies and uses thereof
Inventor: BARNES CARMEN
IPC: C12N15/86
Filed: 2021-09-09
Abstract: Provided are recombinant adeno-associated virus (rAAV) compositions for the expression of antibodies (e.g., anti-complement component 5 (C5) antibodies) in cells, and methods of treating disorders with the same (e.g., disorders associated with C5 activity (
Patent AU-2021359793-A1 (AU)
Title: Solar cell, preparation method for solar cell, and photovoltaic module
Inventor: XIE JUNJIE
IPC: H10K71/15
Filed: 2021-12-07
Abstract: A solar cell, a preparation method for a solar cell, and a photovoltaic module, relating to the technical field of solar energy photovoltaics. The solar cell comprises a crystalline silicon cell unit, and a down-conversion luminescence layer and a perovskite layer sequentially located on the light-facing surface of the crystalline silicon cell unit. The band gap of the perovskite layer becomes gradually smaller in the direction from the light-facing surface to the back surface. The band gap at the back surface of the perovskite layer is greater than or equal to the band gap of an absorption layer of the crystalline silicon cell unit. Because the band gap gradually decreases from large to small, the perovskite layer features a wide absorption spectrum, a long charge carrier free path, higher luminous efficiency, thus being able to broaden the spectral absorption range of the solar cell, and improve energy use and conversion efficiency. The complex processing of multi-layer battery superposition is avoided, the multiple film layer structure is simplified, losses in transmission of charge carriers between film layer interfaces and series structures are avoided, the conversion efficiency of the solar cell is further improved, and the processing difficulty is reduced, facilitating industrial production.
Patent AU-2021377880-A1 (AU)
Title: Hydrogels formed in situ and composition design for intrauterine use
Inventor: BASSETT MICHAEL
IPC: A61K31/4439
Filed: 2021-11-11
Abstract: Medical hydrogel systems for providing improved properties for certain medical applications are described. The hydrogel systems are effective for forming a space filling hydrogel in a body cavity and for the prevention of adhesion formation between tissues within the body cavity following a surgical procedure. Hydrogel delivery systems for transcervical delivery of a premixed precursor solution and an accelerator solution are described. Methods for transcervical installation of intrauterine hydrogels with distended fill are also described. The hydrogel systems, hydrogel delivery systems, and associated methods can be useful for providing degradable hydrogel in the uterine cavity, including the cervical canal, for the prevention of adhesions following intrauterine procedures.
Patent AU-2021404080-A1 (AU)
Title: Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof
Inventor: ANGERS STEPHANE
IPC: C07K16/46
Filed: 2021-12-17
Abstract: Described herein are tetravalent binding antibody molecules comprising a FZD receptor binding domain and an LRP5/6 co-receptor binding domain on opposite termini of an Fc domain that activate a Wnt beta-catenin signaling pathway and methods for their use.
Patent AU-2021415915-A1 (AU)
Title: Secure blockchain data recovery
Inventor: WHITE ERIC
IPC: H04W12/00
Filed: 2021-09-30
Abstract: A first device participating in a blockchain receives an indication of an error in the blockchain being maintained by the first device. The first device determines a defective block of the blockchain and receives a replacement for the defective block from a second device. The first device determines a recalculated blockchain that includes the replacement for the defective block.
Patent WO-2023023800-A1 (WO)
Inventor: MCMURDY STEPHANIE
IPC: A61F13/15
Filed: 2022-08-25
Abstract: A washable moisture absorbent bra for lactating persons is provided that is simple to manufacture, may have improved absorbency and moisture barrier properties, may be more comfortable and enable more freedom of movement, and is environmentally friendly. The bra comprises: first and second cup portions defined by inner and outer layers, the inner layer positioned against the breast of the lactating person when used; and first and second inserts positioned intermediate the inner and outer layers in the first and second cup portions. The inserts comprise a moisture absorbent inner portion, and an outer moisture barrier bonded to the absorbent inner portion. The first and second inserts are provided in central parts of the first and second cup portions such that an insert-free portion is defined between an edge of the first and second inserts and an edge of the first and second cup portions.
Patent AU-2022214760-A1 (AU)
Title: Aqueous blend of pigment and an alkoxylated amine
Inventor: FRANKEL ERICA A
IPC: C09D17/00
Filed: 2022-01-20
Abstract: The present invention is composition comprising water, a pigment and a compound of Formula I: (I) wherein R, R
Patent AU-2022219104-A1 (AU)
Title: Network physical layer configurations for ambulatory physiological parameter monitoring and therapeutic intervention systems
Inventor: ZOSS DAUD
IPC: A61B5/145
Filed: 2022-02-03
Abstract: Certain embodiments herein relate to a physiological parameter monitoring system. The system may include a sensor and sensor electronics connectable to the sensor. The system may also include a transmitter operably connected to the sensor electronics, the transmitter having or being configured to have at least a portion thereof positioned at a first location adjacent to and/or in contact with an external surface of a body of a host during a sensor session, the transmitter further configured to wirelessly transmit sensor information using human body communication. The system may further include a first display device comprising a display and a receiver, the receiver having or being configured to have at least a portion thereof positioned at a second location adjacent to and/or in contact with the external surface of the body during the sensor session, the receiver further configured to receive sensor information from the transmitter using human body communication.
Patent AU-2022224066-A1 (AU)
Title: Single-chain and multi-chain synthetic antigen receptors for diverse immune cells
Inventor: CHAUDHARY PREET
IPC: A61K38/16
Filed: 2022-02-21
Abstract: The disclosure provides single-chain and multi-chain synthetic antigen receptors (SARs), methods of making such synthetic antigen receptors, cells expressing said SARs, nucleic acids encoding said SARS, and uses thereof for the treatment of diseases and disorder. The receptors include unispecific, bispecific, multispecific and universal next generation SAR designs. Also presented are novel accessory modules that can be co-expressed with the SARs of the disclosure, cells expressing said accessory modules with and/or without a SAR, and vectors comprising nucleic acids encoding polypeptides for membrane anchored low-affinity variants of cytokines (e.g., IL-2 and/or IL-15), membrane anchored cytokines with epitope tags, and multi-purpose gene switches that serve suicide, survival and marker functions. In one aspect, the disclosure relates to a novel SAR design that confers TCR-like antigen binding specificity to any cell, including the ability to bind to a peptide antigen in association with an MHC or HLA molecule.
Patent AU-2022224689-A1 (AU)
Title: Topical formulations of a jak 1/3 inhibitor and methods of use thereof for treatment of atopic dermatitis and other skin conditions
Inventor: CHANGELIAN Paul
IPC: C07D471/04
Filed: 2022-02-18
Abstract: The present disclosure relates methods for treating skin disorders caused by an immune deficiency with topical formulations comprising ethyl (R)-4-((1-(2-cyanoacetyl)piperidin-3-yl)amino)-1H-pyrrolo[2,3-b]pyridine-5-carboxylate (Compound I) or pharmaceutically acceptable derivative thereof. In particular, the topical formulations described herein may be used to treat atopic dermatitis, alopecia areata, or vitiligo.
Patent AU-2022229038-A1 (AU)
Title: Synergistic cannabinoid esters, their salts and uses thereof
Inventor: MOUSTAFA MAHMOUD MOHAMED ABDRABO
IPC: C07F9/12
Filed: 2022-03-03
Abstract: Cannabinoid esters and their soluble salts with synergistic or additive therapeutic counterparts and stable formulations thereof, as well as their edible, beverage and medicinal applications. The synergistic or additive cannabinoid esters may be used as drugs or prodrugs for treating various conditions related to the modulation or biased modulation of cannabinoid receptors, including but not limited to, pain and inflammation, arthritis, cancer, glaucoma, neurodegenerative disorders, multiple sclerosis, renal fibrosis, fibrotic disorder, mental health disorders, addiction, motor function disorders and gastrointestinal and metabolic disorders.
Patent AU-2022262648-A1 (AU)
Title: Car nkts expressing artificial micro rna-embedded shrna for downregulation of mhc class i & ii expression
Inventor: HECZEY ANDRAS
IPC: A61K39/00
Filed: 2022-04-22
Abstract: The present disclosure provides methods and compositions related to Natural Killer T cells that are engineered to knock down the expression of one or more endogenous major histocompatibility complex (MHC) gene. The present disclosure also provides engineered CAR NKT cells that resist rejection by allogeneic immune cells both
Patent AU-2022283025-A1 (AU)
Title: Diagnostic for sepsis endotypes and/or severity
Inventor: HANCOCK ROBERT E
IPC: C12Q1/6809
Filed: 2022-05-25
Abstract: The present disclosure relates to methods for classifying a subject into a sepsis mechanistic endotype as well as methods for predicting severity of sepsis in a subject. The methods can comprise use of a biological sample obtained from the subject at first clinical presentation. The classification of the subject into a sepsis mechanistic endotype and/or prediction of severity of sepsis may, for example, allow for treatment of sepsis using an approach suitable to the particular mechanistic endotype and/or severity.
Patent AU-2023200412-A1 (AU)
Title: Chromium containing compositions for improving health and fitness
Inventor: KOMOROWSKI JAMES R
IPC: A61K33/24
Filed: 2023-01-25
Abstract: CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS 
ABSTRACT 
Administration of certain chromium complexes in combination with a starch provide 
unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise 
tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle 
endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle 
protein breakdown, and fat mass.
Patent AU-2023201628-A1 (AU)
Title: Floor structure
Inventor: IIHOSHI Chikara
IPC: E04B5/02
Filed: 2023-03-15
Abstract: Provided is a floor structure placed on a floor frame in which a plurality of beams are 
juxtaposed, the floor structure including: a plate-shaped floor material placed on the plurality of 
beams; and a plate-shaped AAC panel placed on the floor material, in which the AAC panel is 
fixed to the floor material so that a lower surface of the AAC panel is in surface contact with an 
upper surface of the floor material, and generates deflection together with the floor material 
when a load is applied to an upper surface of the AAC panel and generates friction with the floor 
material when vibration occurs to attenuate the vibration.  
19425876_1 (GHMatter) P115953.AU
Patent WO-2005116778-A1 (WO)
Title: Composition de toner durcissable par rayonnement
Inventor: OP DE BEECK WERNER
IPC: G03G9/087
Filed: 2005-05-26
Abstract: L'invention concerne des particules de toner sèches comprenant au moins une résine durcissable par rayonnement et un agent de coloration, la résine durcissable par rayonnement contenant un mélange (a) d'une résine d'époxy/polyester (méth)acrylée et (b) d'une résine de polyuréthane (méth)acrylée. De préférence, lorsque des images de toner fusionnées et durcies pouvant être obtenues à partir de ces particules de toner sèches sont obtenues sur un substrat utilisé pour leur développement, ces images présentent un nombre de frottement équivalent (ERN) supérieur à 6, où ERN = résistance au frottement MEK / (dose de rayonnement*meq/g), meq/g désignant la quantité milliéquivalente de doubles liaisons par gramme de cette résine durcissable par rayonnement, ainsi qu'un comportement de viscosité caractérisé en ce que la viscosité à 140°C est inférieure à la viscosité à 120°C.